Kadcyla

{
  "id": "MLC-T-ONC-004603",
  "term": "Kadcyla",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat certain patients with HER2-positive breast cancer that has already been treated with trastuzumab and a type of anticancer drug called a taxane. It is also being studied in the treatment of other types of cancer. Kadcyla contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. Kadcyla is a type of antibody-drug conjugate. Also called ado-trastuzumab emtansine and T-DM1.",
  "synonyms": [
    "ado-trastuzumab emtansine",
    "T-DM1"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/kadcyla/"
}